Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Treasury Shares (2025)

Neuphoria Therapeutics (NEUP) has disclosed Treasury Shares for 1 consecutive years, with $33915.0 as the latest value for Q3 2025.

  • Quarterly Treasury Shares changed N/A to $33915.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $33915.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $33915.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares for Q3 2025 was $33915.0 at Neuphoria Therapeutics, roughly flat from $33915.0 in the prior quarter.
  • The five-year high for Treasury Shares was $33915.0 in Q2 2025, with the low at $33915.0 in Q2 2025.